TORONTO, Ontario, June 1, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL)(CSE:SL.CN)(CNSX:SL)(OTC PINK:SPRWF) is pleased to announce that it has received final approval from the TSX Venture Exchange (“TSX.V”) to list the Company’s common shares on the TSX.V. The common shares are expected to begin trading on the TSX.V at the opening of markets on June 6, 2017 under the symbol “FIRE”.
Tag Archives: SL
Supreme Updates Board of Directors and Provides Licensing Update
TORONTO, Ontario, May 8, 2017 /Weed Wire/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL)(CSE:SL.CN)(CNSX:SL) is pleased to announce that Mr. Ron Factor, B.A.Sc, MBA, has joined its Board of Directors.
Supreme Announces Conditional Approval to List on the TSX.V
TORONTO, Ontario, April 10, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL)(CSE:SL.CN) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (“TSX.V”) to list the Company’s common shares on the TSX.V.
Supreme Pharmaceuticals Closes $55 Million Offering
TORONTO, Ontario, Dec. 13, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL) is pleased to announce the closing of its $50 million bought deal private placement (the “Brokered Offering”) and concurrent $5 million non-brokered private placement (together with the Brokered Offering, the “Offering”) for aggregate gross proceeds of $55 million.
Supreme Provides Clarification Regarding Health Canada Website
TORONTO, Ontario, Oct. 27, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(CSE:SL.CN)(OTC PINK:SPRWF) wishes to clarify that, as a result of changes Health Canada made to its website today.
Supreme Issues Incentive Stock Options
TORONTO, Ontario, Sept. 14, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) has issued 130,000 stock options (each an ” Option “) to a consultant of the Company.
Supreme Closes Private Placement for Aggregate Proceeds of $14,949,755
TORONTO, Ontario, Aug. 30, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the third tranche of its previously announced non-brokered private placement (the “Financing”) for proceeds of $10,610,625 and aggregate proceeds from three tranches of $14,949,755.
Supreme Closes $4 Million Mortgage
TORONTO, Ontario, Aug. 8, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce that it has closed a $4,000,000 mortgage (the “Mortgage”) with a private lender.
Supreme Closes Second Tranche of Private Placement for Aggregate Proceeds of $4.34m and Secures Additional Long Term Supply Agreement
TORONTO, Ontario, July 15, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the second tranche of its previously announced non-brokered private placement (the “Financing”) for proceeds of $723,250 and aggregate proceeds from both tranches of $4,339,130.
Supreme Obtains MMPR License to Cultivate Medical Marijuana
TORONTO, ON, March 11, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF)(CSE:SL) is pleased to announce its wholly-owned subsidiary, Advanced Medical Marihuana Canada (“AMMCan”) has been granted a license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the “MMPR”).
Understanding Canadian Public Markets
While investment in cannabis industries is limited in the U.S. by federal law, Canadian companies and investors don’t face these same restrictions.